Bhringraj for Hair Growth: The King of Herbs That Outperformed Minoxidil - Alak Gentlemen

Bhringraj for Hair Growth: The King of Herbs That Outperformed Minoxidil

 

Most men have heard of minoxidil. Far fewer have heard of the herb that outperformed it in a controlled study — a plant that has been used in Ayurvedic medicine for over a thousand years, growing in fields across India, largely ignored by the mainstream hair care industry.

That herb is Bhringraj — and the evidence for bhringraj for hair growth is stronger than most men realise.

Known in Ayurveda as Kesharaja — literally "King of Hair" — the evidence for bhringraj for hair growth goes far beyond folklore. It is one of the most researched botanical ingredients for hair loss in the world, with human clinical trials, animal studies, and molecular-level research now confirming what traditional Ayurvedic physicians documented in classical texts centuries ago. If you are dealing with hair fall and thinning, or early baldness, this blog covers everything you need to know about bhringraj for hair growth — the evidence, the mechanism, and why Alak uses it at the heart of its formula.


What Is Bhringraj?

Bhringraj is a flowering herb belonging to the family Asteraceae, found throughout tropical and subtropical India. It has been employed for centuries in Ayurvedic, Siddha, Unani, and Traditional Chinese Medicine for hair-growth-promoting and rejuvenative purposes.

Eclipta alba hair growth research confirms what its bioactive compounds make clear. The ethanol extract of Eclipta alba contains wedelolactone and ecliptine as its major phytochemicals, along with flavonoids, triterpenoid saponins, and phytosterols — compounds with antioxidant, anti-inflammatory, and vasodilatory properties. Each of these compounds acts on a distinct aspect of scalp and follicle health — which is why Bhringraj's action is broader than most single-mechanism pharmaceutical treatments.


The Study That Changed Everything: Bhringraj vs Minoxidil

The most significant piece of evidence for Bhringraj for hair growth comes from a landmark study published in the journal Archives of Dermatological Research. Petroleum ether and ethanol extracts of Eclipta alba were evaluated for hair growth promotion, with minoxidil 2% solution serving as the positive control for comparison. Hair growth initiation time was significantly reduced to half on treatment with the extracts, as compared to control animals. The time required for complete hair growth was also significantly reduced.

The Bhringraj group had more follicles in anagen phase — 69 — compared to the minoxidil group's 47. More follicles in the anagen (active growth) phase means denser, thicker hair — and a measurably higher anagen-to-telogen ratio. The herb did not just match minoxidil — it surpassed it on this critical metric.

A 2025 molecular study published in Essential Chemistry went further, employing state-of-the-art phytochemical and cell-biological assays to determine the molecular mechanisms behind Eclipta alba's hair growth activity — confirming wedelolactone as the primary active compound responsible for dermal papilla cell stimulation.

And in 2025, the first structured human clinical trial was completed. Fifty-four participants with increased hair shedding received standardised oral Eclipta alba extract tablets for 24 weeks. Comb test counts decreased from 72.4 hairs at baseline to 27.1 at Week 24 — a 62.5% reduction (p less than 0.0001). Weekly diary counts declined from 512.6 to 205.4 — a statistically significant reduction in daily shedding.

A 62.5% reduction in hair fall in 24 weeks — without any DHT-blocking pharmaceutical — is a clinical result, not a marketing claim.


How Bhringraj Works: 5 Mechanisms on the Hair Follicle

Bhringraj does not work through a single pathway. Its effectiveness comes from simultaneously addressing multiple mechanisms of hair loss — which is why it performs the way it does against pharmaceutical single-action treatments.

1. Dermal Papilla Cell Stimulation Wedelolactone — Bhringraj's primary active compound — directly stimulates dermal papilla cell proliferation while also exhibiting DHT-inhibitory properties at the follicle level. These are the cells at the base of each follicle that control whether the follicle stays in the growth phase or enters dormancy. More active dermal papilla cells means more follicles growing, for longer.

2. Anagen Phase Prolongation Numerous experimental studies have demonstrated that Bhringraj extracts stimulate hair follicle activity and prolong the anagen (growth) phase of hair. The anagen phase is when hair is actively growing — extending it means each strand grows longer and thicker before it sheds.

3. Scalp Microcirculation Enhancement Bhringraj has documented vasodilatory properties that increase DHT-independent scalp blood flow — it widens the small blood vessels around the hair follicle, improving the delivery of oxygen and nutrients to the follicle base. This is similar in mechanism to minoxidil, but achieved through natural phytochemical action rather than synthetic vasodilation.

4. DHT Inhibition New studies indicate that Eclipta alba extract can act in the same way as 5-alpha reductase inhibitors such as finasteride, acting as a natural DHT blocker. DHT — dihydrotestosterone — is the hormone primarily responsible for follicle miniaturisation in male pattern baldness, and blocking it is central to any effective hair loss strategy. Bhringraj's ability to inhibit its production adds a hormonal dimension that purely vasodilatory treatments like minoxidil lack entirely.

5. Anti-inflammatory and Antioxidant Scalp Protection The flavonoids in Bhringraj — including apigenin and luteolin — have strong antioxidant and anti-inflammatory properties at the scalp level, while triterpenoid saponins provide antibacterial and antifungal effects. Scalp inflammation is one of the most underappreciated contributors to hair loss in Indian men. Pollution, hard water, seborrheic dermatitis — all create a chronic inflammatory state around the follicle that gradually compromises its health. Bhringraj addresses DHT-independent scalp damage at the root.



Clinical Evidence Summary: Bhringraj for Hair Growth

Study Type Key Finding Year
Eclipta alba vs Minoxidil 2% — male albino rats Animal (controlled) Bhringraj reduced hair growth initiation time to half vs control; 69 anagen follicles vs minoxidil's 47 2008
Standardised Bhringaraj extract tablets — 24-week trial Human prospective trial 62.5% reduction in comb-test hair fall (p < 0.0001); weekly diary counts fell from 512 to 205 over 24 weeks 2025
Molecular insights into Eclipta alba hair mechanisms In vitro / phytochemical Confirmed wedelolactone and ecliptine as primary actives; strong binding to VEGF receptor (−7.9 kcal/mol) 2025
In vitro 5-alpha reductase inhibition — Ayurvedic herbs Laboratory Eclipta alba demonstrated significant 5-alpha reductase inhibitory activity vs finasteride control 2024
Comprehensive phytochemical review — Eclipta alba Systematic review Confirmed multi-target mechanisms: anagen induction, DHT inhibition, anti-inflammatory, antifungal 2025

Sources: Archives of Dermatological Research (PubMed), Journal of Ayurveda and Integrated Medical Sciences, Essential Chemistry (Tandfonline)


Why Bhringraj Has Been Underused — And Why That Is Changing

The honest answer is that Bhringraj's clinical validation was slow to accumulate. Traditional use preceded the science by a thousand years, and pharmaceutical companies had little incentive to fund research on an herb they could not patent.

That gap is now closing. The 2025 human clinical trial — the first of its kind — joins a body of laboratory, animal, and molecular research that collectively makes Bhringraj one of the most evidence-aligned Ayurvedic hair loss treatments available. The consistent use of Eclipta alba across diverse traditional medical systems for hair-growth-promoting purposes provides a strong ethnopharmacological foundation for modern scientific investigation.

What has changed is the delivery format. Traditional Bhringraj oil, applied briefly and washed off, cannot deliver the herb's bioactive compounds to the follicle in therapeutically meaningful concentrations. The oil sits on the shaft, not at the root. The dwell time is too short.


How Alak Delivers Bhringraj to Where It Matters

Alak's formulation is built around a boiling and fermentation process specifically designed to solve the delivery problem. Whole Bhringraj is slow-boiled to break down its cellular structure and release wedelolactone, ecliptine, and its full suite of flavonoids into a water-soluble solution. The solution is then fermented — a process that increases bioavailability and scalp absorption — and strained into Alak's water-based overnight formulation.

Water-based formulations penetrate the scalp at a molecular level that oil-based products cannot match. Applied overnight as part of Alak's Ayurvedic scalp formulation, Bhringraj's active compounds have 6–8 uninterrupted hours to interact with the dermal papilla, stimulate follicle activity, and work on the scalp's inflammatory and microcirculatory environment. This is the dwell time the clinical studies reflect. This is what makes it work.

Bhringraj is the follicle stimulation core of Alak's Ayurvedic formula. Amla handles DHT inhibition. Ashwagandha manages stress and cortisol. Brahmi extends the anagen phase from a hormonal direction. Together, these ingredients cover the full spectrum of male hair loss — which no single ingredient, herbal or pharmaceutical, can do alone.

Whether you are just starting or switching from a pharmaceutical, bhringraj for hair growth is one of the most evidence-backed decisions you can make. Read more about how all 11 ingredients work together: 11 Powerful Ayurvedic Ingredients in Alak for Male Hair Loss


What Results to Expect — Realistically

As a bhringraj hair loss treatment, results are not a two-week fix. The 2025 clinical trial ran for 24 weeks — six months — and showed progressive improvement across the full period, with the most significant change between weeks 12 and 24.

In practice, most men using Alak notice reduced daily hair fall between weeks 4–8. Hair fall reduction is typically the first measurable signal before visible regrowth begins. Visible density improvement typically follows between weeks 10–16 for early to moderate hair loss. The 90-day commitment — three bottles — is the minimum required to assess whether the treatment is working for your specific pattern of hair loss.


Give Bhringraj the dwell time it needs. Alak's 3-Bottle Pack delivers Bhringraj alongside 10 complementary Ayurvedic ingredients in a water-based overnight formula — the only format that gets the herb to your follicle.

👉 Shop the Alak 3-Bottle Pack — 90 Days of Natural Hair Revival


External References


This article is for informational purposes only. Clinical studies referenced are ingredient-level research. Individual results vary. Consult a dermatologist for severe or sudden hair loss.

Back to blog

Leave a comment